Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Dr. Gandara Discusses Clinical Implications of the FLAURA Study in NSCLC

October 16th 2017

David R. Gandara, MD, director, Thoracic Oncology Program, professor, senior advisor to director, UC Davis Comprehensive Cancer Center, discusses the significance of the phase III FLAURA trial of first-line osimertinib (Tagrisso) in EGFR-mutant non-small cell lung cancer (NSCLC).

Dr. Ross on Biomarker Research Development in Liver Metastasis

October 11th 2017

Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses biomarker research development for patients with liver metastasis.

PEGPH20: Future Directions in Pancreatic Adenocarcinoma

October 10th 2017

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

October 10th 2017

Pancreas Cancer Treatment Forecast

October 10th 2017

Pancreas Cancer: Investigational Targeted Approaches

October 10th 2017

Clinical Research in the Treatment of Pancreas Cancer

October 10th 2017

Management of Borderline Resectable Pancreas Cancer

October 10th 2017

Neoadjuvant Therapy Recommendations in Pancreas Cancer

October 10th 2017

Role of Adjuvant Radiation Therapy in Pancreas Cancer

October 10th 2017

Adjuvant Therapy Recommendations in Pancreas Cancer

October 10th 2017

Pancreas Cancer: Incorporating Nanoliposomal Irinotecan

October 10th 2017

Palliative Care Recommendations in Pancreas Cancer

October 10th 2017

Modifying Chemotherapy Regimens in Pancreas Cancer

October 10th 2017

Sequential Therapy for Metastatic Pancreas Cancer

October 10th 2017

Precision Medicine for Pancreatic Cancer

October 10th 2017

Biological Breakthroughs in Pancreas Cancer

October 10th 2017

Precision Medicine Has Emerging Role in mCRPC

October 6th 2017

Andrew J. Armstrong, MD, discusses emerging treatments and techniques for precision medicine in metastatic castration-resistant prostate cancer.

HR+ Breast Cancer: Updated Results From MONARCH Trials

October 2nd 2017

Abemaciclib's Value in Treating HR+ Breast Cancer

October 2nd 2017